SMARTDIAGNOS – Sepsis-Früherkennung
Sepsis - also known as blood poisoning - is a life-threatening condition that occurs when the body's immune system is unable to respond appropriately to an infection. The result is an attack on one's own tissue and organs. Due to its frequent occurrence and high mortality rate, sepsis is one of the biggest health policy problems worldwide. Early diagnosis is crucial in the treatment of sepsis. Previous diagnostic procedures take too long and are too insensitive. For this reason, it is necessary to improve sepsis diagnostics.
Since 2016, the DIN Standards Committee for Medicine (NAMed) has been a partner in the four-year SMARTDIAGNOS research project. The project is funded by the EU Framework Programme for Research and Innovation Horizon 2020 and brings together a consortium of 10 leading scientific institutions, European organisations and companies led by the Danish Technical University DTU Nanotech.
The objective is to accelerate and specify sepsis diagnostics by integrating numerous analytical steps into an optimized system. The consortium is developing a procedure for diagnostics in the emergency department and a procedure for analysis for use in the laboratory. These methods should provide fast results and show a higher sensitivity and selectivity.
February 2016 until January 2020
- Technical University of Denmark (DK)
- Copenhagen Business School (DK)
- TATAA Biocenter (SE)
- ZOETIS (DK)
- Anagnostic Bioanalysis (AT)
- Unilabs (SE)
- Högskolan i Skövde (University of Skövde) (SE)
- Charles University in Prague (CZ)
- Danube University Krems (AT)
- Deutsches Institut für Normung e. V. (DE)
Funding Code: H2020 687697